comparemela.com

Latest Breaking News On - James lanthier - Page 8 : comparemela.com

Mindset Pharma chooses pair of psychedelic drug candidates to move Family 2 program forward

Mindset Pharma chooses pair of psychedelic drug candidates to move Family 2 program forward
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Mindset Pharma says licensing agreement with Cybin gives it multiple shots for the goal

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) CEO James Lanthier joins Proactive s Stephen Gunnion with details of an exclusive licensing agreement for Cybin.

Mindset Pharma Provides Strategic Intellectual Property License to Cybin

27.09.2022 - Licensing Subset of Mindset’s Family 1 Intellectual Property Underscores Strength of Mindset’s Portfolio and Business StrategyTORONTO, Sept. 27, 2022 (GLOBE NEWSWIRE) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset”), a drug . Seite 1

NA Proactive news snapshot: KULR Technology Group Inc, World Copper Ltd, Outlook Therapeutics Inc, CleanSpark Inc, Plurilock Security Inc, Majuba Hill Copper Corp, Nickel North Exploration Corp,Nevada Copper Corp, Mindset Pharma Inc, EverGen Infrastructur

Nano One Materials Corp (TSX:NANO, OTC:NNOMF) and Euro Manganese Inc (ASX:EMN, TSX-V:EMN, OTCQX:EUMNF) announced positive news in their joint development.

Mindset Pharma Inc provides strategic intellectual property license to Cybin Inc for preclinical psychedelic drug research

Mindset Pharma Inc provides strategic intellectual property license to Cybin Inc for preclinical psychedelic drug research
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.